Senator Collins Receives Trailblazer Award from JDRF
There is no question that our nation’s health care system requires substantial reform. The status quo of soaring health care costs, struggling families, and health care provider shortages across Maine and the nation is unacceptable. Senator Collins frequently works with her colleagues on both sides of the aisle to address these and other important issues facing our nation such as improved mental health care, drug treatment programs, supporting America’s caregivers, and nutrition programs.
As a native to northern Maine, Senator Collins understands the specific challenges that rural communities face for medical care. Throughout her time in the Senate, Senator Collins has consistently supported programs to expand access to and improve the health care system, particularly for citizens living in rural areas.
As a freshman legislator, Senator Collins founded the Senate Diabetes Caucus and has since led the effort to more than triple federal funding for diabetes research.
Senator Collins’ Statement on Administration Examining Drug Importation to Lower Prescription Drug Prices
Washington, D.C. - U.S. Senator Susan Collins issued this statement following today’s announcement by the Administration that it is exploring how to safely import prescription drugs from other countries in the event of a dramatic price increase for a drug produced by one manufacturer and not protected by a patent. Department of Health and Human Services Secretary Alex Azar asked Food and Drug Administration Commissioner Scott Gottlieb to establish a working group on this topic.
Senator Collins Questions Health Care Leaders on Reducing Costs and Improving Quality
Senator Collins Questions Health Care Leaders on Reducing Costs and Improving Quality
Senators Collins, King Announce Jackson Laboratory to Receive $4.1 Million Over Five Years to Research Alzheimer’s Disease
WASHINGTON, D.C. – Today, U.S. Senators Susan Collins (R-Maine), the founder and co-chair of the Congressional Task Force on Alzheimer’s disease, and Angus King (I-Maine) announced that The Jackson Laboratory in Bar Harbor has been awarded $873,647 for the year to study the progression and genetic causes of Alzheimer’s. The award is a part of a five-year allocation that will ultimately amount to $4,191,258 by 2023. The funds were awarded by the U.S. Department of Health and Human Services’ (DHHS) National Institute on Aging.
FDA Approves New Options for Managing Diabetes Following Strong Push from Senator Collins
Washington, D.C. – U.S. Senator Susan Collins, the Chairman of the Aging Committee and the founder and co-chair of the Senate Diabetes Caucus, applauded the U.S. Food and Drug Administration’s (FDA) approval of two advances in diabetes technologies that will help millions of Americans suffering from diabetes better manage the disease.
Senators Collins, King Announce More Than $1 Million in Funding for Maine Primary Care Association
WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King announced that the U.S. Department of Health and Human Services (HHS) has awarded $1,021,441 to the Maine Primary Care Association (MPCA). This funding was allocated through the Department’s Health Resources and Services Administration (HRSA).
Senators Collins, King Announce $100,000 in Funding for Healthy Community Coalition of Greater Franklin County
WASHINGTON D.C. – U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) announced today that the U.S. Department of Health and Human Services has awarded Healthy Community Coalition of Greater Franklin County (HCC) a grant of $100,000. The Department’s Health Resources & Services Administration (HRSA) will provide the funding through its Rural Health Network Planning Grant Program, which promotes the planning and development of health care networks in order to increase efficiency, improve care and strengthen the rural health care system as a whole.
Senate Committee Passes Collins-backed Legislation to Counter Rising Prescription Drug Prices
Washington, D.C. - The Senate Judiciary Committee passed legislation, cosponsored by U.S. Senator Susan Collins, to address the rising costs of prescription drugs. The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act would deter pharmaceutical companies from blocking lower-cost generic alternatives from entering the marketplace.
Secretary Azar Pledges to Work with Senator Collins on Legislation to Prohibit Gag Clauses That Cause Consumers to Overpay for Medications
Medicare Will Allow Beneficiaries to Use Smartphone Apps to Unlock Full Potential of Continuous Glucose Monitors Following Bipartisan Advocacy by Senators Collins, Shaheen
Washington, D.C. — U.S.
Collins, King Applaud FCC Proposal to Increase Funding for Rural Health Care Program
WASHINGTON, D.C. – Today, U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) applauded a draft proposal from Federal Communications Commission (FCC) Chairman Ajit Pai that would significantly increase funding for the Universal Service Fund’s Rural Health Care (RHC) Program.
Senator Collins Raises Budget Issues Faced by Maine Hospitals that Qualify for Discounted Pharmaceuticals
Click HERE to watch Senator Collins’ Q&A with Ms. Maxwell
Senator Collins Questions FDA Commissioner about High Cost of Prescription Drugs, ‘Broken’ Rebate System
Click HERE to watch Senator Collins’ Q&A
Senators Collins and King Join Bipartisan Group of 30 Senators in Urging FCC to Expand Rural Health Program
Washington, D.C. - U.S. Senators Susan Collins (R-ME) and Angus King (I-ME) joined a bipartisan group of 30 U.S. Senators in urging the Federal Communications Commission (FCC) to increase the funding cap for a program aimed at improving the quality of health care available to patients in rural areas.
Senators Collins, Shaheen Urge CMS to Provide Coverage for Glucose Monitoring Smartphone Apps
Washington, D.C. – The co-chairs of the Senate and House Diabetes Caucus, U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH) and U.S. Representatives Tom Reed (R-NY) and Diana DeGette (D-CO), sent a letter to Seema Verma, Administrator of the Centers for Medicare and Medicaid Services (CMS), urging the agency to review a Medicare policy that prohibits beneficiaries from using smartphone applications in conjunction with their continuous glucose monitors (CGM).
Legislation to Lower Health Insurance Premiums in Individual Market by up to 40% Proposed for Omnibus Spending Bill
Would also help those who are below 250% of the poverty level who receive government assistance to help them pay for their deductibles and co-pays
“A self-employed plumber making $60,000 may be paying $20,000 for health insurance. Our proposal could cut up to $8,000 from that insurance bill.”
—Sens. Lamar Alexander and Susan Collins, Congressmen Greg Walden and Ryan Costello
Leading Health Care and Business Groups Urge Congress to Take Action to Lower Health Care Premiums
Leading health care and business groups joined together this morning to call on Congressional Leadership to take urgent action to reduce premiums for millions of Americans and their families.
Dear Leaders McConnell and Schumer, Speaker Ryan, and Leader Pelosi:
Americans need action now.
We came together earlier this month to stress the importance of congressional action to lower healthcare premiums. Time is running out.
Senator Collins Honored by Research!America for Her Strong Advocacy for Biomedical Research
Click HERE for a high-quality photo of Senator Collins with Congressma
Senators Collins, McCaskill, Stabenow Lead Bipartisan Group of Senators in Introducing Legislation to Prohibit “Gag Clauses” That Cause Consumers to Pay Higher Prices for Prescription Drugs
Washington, D.C. — Today, U.S. Senators Susan Collins (R-ME), Claire McCaskill (D-MO), and Debbie Stabenow (D-MI) led a bipartisan group of Senators in introducing two bills to remove barriers that prevent patients from paying the lowest possible price for prescription drugs. The Patient Right to Know Drug Prices Act and the Know the Lowest Price Act would prohibit health insurers and pharmacy benefit managers from using “pharmacy gag clauses” – an egregious practice that some companies use to conceal prices from patients at the pharmacy.
Report: Individual Insurance Premiums Next Year 40% Lower Under Alexander-Murray, Collins-Nelson Than if Congress Doesn’t Act
Washington, D.C.
Government Funding Bill Includes Provisions to Address Doctor Shortages & Train Next Generation of Physicians
Washington, D.C. — Following a bipartisan effort led by Senators Susan Collins (R-ME) and Jon Tester (D-MT), the government funding bill will extend and provide $126.5 million for each of fiscal years 2018 and 2019 for the successful Teaching Health Centers Graduate Medical Education Program, which trains physicians in underserved, community-based settings.
Full 2-Year Reauthorization of Special Diabetes Program Included in Funding Bill
Washington, D.C. – Following a bipartisan push from U.S.
Following a Longtime Effort from Senators Collins and Shaheen, Medicare May Now Provide Coverage for New Lifesaving Diabetes Therapies
Washington, D.C. — U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), the co-chairs of the Senate Diabetes Caucus, released the following statement after the Centers for Medicare and Medicaid Services (CMS) announced that new technologies used for the delivery of insulin, such as the Omnipod system, may now be covered under Medicare Part D.
Majority Leader McConnell, Speaker Ryan Release Statement Recognizing Senator Collins’ Effort to Prevent $25 Billion Cut to Medicare
Washington, D.C.—Following the passage of a continuing resolution that includes a provision preventing an automatic cut to Medicare, Majority Leader Mitch McConnell (R-KY) and Speaker Paul Ryan (R-WI) released a statement recognizing Senator Collins’ efforts to ensure this $25 billion reduction did not go into effect.
Congress Averts $25 Billion Cut to Medicare Following Effort Led by Senator Collins
Senator Collins urged swift action to avert these cuts and secured commitments from Majority Leader McConnell and Speaker Ryan to avoid an automatic 4% cut to Medicare
Click HERE to watch Senator Collins’ remarks on the Senate floor
Collins, Klobuchar, Baldwin Press Strongbridge Biopharma for Answers on Dramatic Price Increase for Keveyis Drug that Treats Glaucoma and Rare Genetic Disease
Washington, D.C. - U.S. Senators Susan Collins (R-ME), Amy Klobuchar (D-MN), and Tammy Baldwin (D-WI) have pressed Strongbridge Biopharma for answers on the dramatic price increase for Keveyis, formerly known as Daranide, a drug that treats glaucoma and a type of rare genetic disease known as periodic paralysis, which causes attacks of muscle weakness or loss of muscle movement. After a series of companies bought and sold the right to the decades-old dichlorphenamide, the list price was hiked from $50 to $13,650 for 100 pills in 2015.
NAIC Says the Provisions of Alexander-Murray and Collins-Nelson Will Significantly Reduce Health Insurance Premiums, Stabilize the Individual Market
Washington, D.C.
Collins, King Join Bipartisan Group of Senators to Urge Congressional Leadership to Commit Resources to Opioid Epidemic
WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King joined a bipartisan group of nine senators in a letter to Leaders McConnell (R-Ky.) and Schumer (D-N.Y.) today calling on them to provide states like Maine with the resources they need to tackle the ongoing opioid epidemic. In their letter, the bipartisan group urged Senate leadership to include additional funding dedicated to addressing the public health crisis in the upcoming supplemental and omnibus appropriations legislation.
Leading Health Care Experts at Oliver Wyman Show Alexander-Murray, Collins-Nelson Will More Than Offset Impact of Individual Mandate Repeal
Washington, D.C.
Senator Collins Questions Experts on Ways to Reduce Prescription Drug Costs
Click HERE to watch Senator Collins’ Q&A with hearing witnesses
Pages
